Aytu BioPharma (0A8M.LSE) Q2 2024 Earnings

15MayConfirmed
Q2 2024
-0.64
-0.6
-0.56
-0.52

Details

Expected EPS
-0.64
Actual EPS
-0.52
Surprise EPS
0.12
Surprise Percent
+18.75%

Description

Aytu BioPharma (0A8M.LSE) has reported earnings of -0.52 per share for Q2 2024.

0 Comments

Share your thoughts